Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Central Nervous System Neoplasms|Neoplasm Metastasis
Interventions: DRUG: Temozolomide
Sponsor: Tufts Medical Center